• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

    0.8506 +0.1806 (+26.96%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,714,033
    Open 0.7500
    Bid (Size) 0.8200 (2,800)
    Ask (Size) 0.8300 (100)
    Prev. Close 0.6700
    Today's Range 0.7400 - 0.8950
    52wk Range 0.6400 - 7.290
    Shares Outstanding 54,291,754
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top movers in Thursday's session ↗
    Via Chartmill
    Thursday's session: gap up and gap down stocks ↗
    Via Chartmill

    Performance

    YTD
    +12.1%
    +12.1%
    1 Month
    +13.6%
    +13.6%
    3 Month
    -12.2%
    -12.2%
    6 Month
    -82.8%
    -82.8%
    1 Year
    -75.4%
    -75.4%

    More News

    Read More
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Deadline Soon: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Which stocks are moving after the closing bell on Tuesday? ↗
    Via Chartmill
    News headline image
    Bragar Eagel & Squire, P.C. Urgently Reminds Stockholders of Molina, aTyr, and Marex to Contact the Firm Before Upcoming Deadlines
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    Shareholders of aTyr Pharma, Inc. Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Bragar Eagel & Squire, P.C. Urges Investors of aTyr, Marex, Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Investors Who Lost Money on aTyr Pharma, Inc. (ATYR) Should Contact Levi & Korsinsky About Pending Class Action - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    Investors Who Lost Money on aTyr Pharma, Inc. (ATYR) Should Contact Levi & Korsinsky About Pending Class Action - ATYR
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via NewMediaWire
    Topics Fraud Lawsuit
    News headline image
    aTyr Pharma, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 8, 2025 to Discuss Your Rights - ATYR
    Via TheNewswire.com
    Topics Fraud Lawsuit

    Frequently Asked Questions

    Is aTyr Pharma, Inc. - Common Stock publicly traded?
    Yes, aTyr Pharma, Inc. - Common Stock is publicly traded.
    What exchange does aTyr Pharma, Inc. - Common Stock trade on?
    aTyr Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for aTyr Pharma, Inc. - Common Stock?
    The ticker symbol for aTyr Pharma, Inc. - Common Stock is ATYR on the Nasdaq Stock Market
    What is the current price of aTyr Pharma, Inc. - Common Stock?
    The current price of aTyr Pharma, Inc. - Common Stock is 0.8506
    When was aTyr Pharma, Inc. - Common Stock last traded?
    The last trade of aTyr Pharma, Inc. - Common Stock was at 01/29/26 04:00 PM ET
    What is the market capitalization of aTyr Pharma, Inc. - Common Stock?
    The market capitalization of aTyr Pharma, Inc. - Common Stock is 46.18M
    How many shares of aTyr Pharma, Inc. - Common Stock are outstanding?
    aTyr Pharma, Inc. - Common Stock has 46M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.